Division of Cardiology

Medicine & Life Sciences

1. Action Potentials 7%
2. Acute Coronary Syndrome 11%
3. American Heart Association 10%
4. Angioplasty 12%
5. Aortic Valve 8%
6. Atherosclerosis 10%
7. Atrial Fibrillation 17%
8. Biomarkers 8%
9. Blood Pressure 18%
10. Blood Vessels 9%
11. Calcium 7%
12. Cardiac Arrhythmias 14%
13. Cardiac Catheterization 7%
14. Cardiac Myocytes 21%
15. Cardiac Resynchronization Therapy 9%
16. Cardiology 18%
17. Cardiomyopathies 18%
18. Cardiotoxicity 8%
19. Cardiovascular Diseases 24%
20. Cholesterol 7%
21. Clinical Trials 7%
22. Confidence Intervals 15%
23. Contrast Media 7%
24. Coronary Artery Bypass 7%
25. Coronary Artery Disease 21%
26. Coronary Disease 12%
27. Coronary Vessels 13%
28. Costs and Cost Analysis 8%
29. Diastole 8%
30. Dilated Cardiomyopathy 8%
31. Dissecting Aneurysm 7%
32. Dogs 8%
33. Echocardiography 16%
34. Elderly 9%
35. Electrocardiography 9%
36. Equipment and Supplies 10%
37. Exercise 12%
38. Fatty Acids 10%
39. Fluorocarbons 9%
40. Genes 12%
41. Guidelines 10%
42. Health 10%
43. Heart 44%
44. Heart Diseases 13%
45. Heart Failure 100%
46. Heart Rate 19%
47. Heart Transplantation 8%
48. Heart Ventricles 8%
49. Heart-Assist Devices 22%
50. Hemodynamics 11%
51. Hemorrhage 8%
52. Hospital Mortality 6%
53. Hospitalization 13%
54. Hypertension 11%
55. Incidence 6%
56. Infarction 13%
57. Inflammation 8%
58. Ischemia 7%
59. Left Ventricular Dysfunction 14%
60. Left Ventricular Function 15%
61. Lipids 10%
62. Macrophages 11%
63. Medicare 16%
64. Meta-Analysis 8%
65. Mitral Valve 6%
66. Molecular Imaging 12%
67. Mortality 32%
68. Muscle Cells 11%
69. Mutation 6%
70. Myocardial Infarction 52%
71. Myocardial Ischemia 11%
72. Myocardium 17%
73. Nanoparticles 15%
74. Neoplasms 7%
75. Odds Ratio 10%
76. Patient Readmission 8%
77. Percutaneous Coronary Intervention 27%
78. Phenotype 8%
79. Placebos 6%
80. Population 11%
81. Pressure 12%
82. Proteins 8%
83. Quality of Life 7%
84. Randomized Controlled Trials 9%
85. Registries 24%
86. Safety 8%
87. Stents 11%
88. Stroke 13%
89. Stroke Volume 16%
90. Survival 9%
91. Therapeutics 22%
92. Thrombosis 8%
93. Transcatheter Aortic Valve Replacement 11%
94. Transplants 10%
95. Tumor Necrosis Factor-alpha 8%
96. Ultrasonics 7%
97. Ventricular Pressure 10%
98. Ventricular Remodeling 9%
99. Veterans 8%
100. Wounds and Injuries 7%